Clinical Trial Update: PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

View source ↗

Summary

This clinical trial update reports the completion of a study assessing the usefulness of 18F-FDG PET/CT in patients with metastatic castration-resistant prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Prostate Cancer | Status: COMPLETED